BIOMAT Database Logo BIOMAT Database Logo

Maternal immunization with pneumococcal surface protein A provides the immune memories of offspring against pneumococcal infection. 2023

Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Department of Otorhinolaryngology-Head and Neck Surgery, Wakayama Medical University, Wakayama, Japan.

Streptococcus pneumoniae (S. pneumoniae) is one of the most widespread pathogens in the world and one of the largest infectious causes of infant mortality. Although current vaccines have various benefits, antibiotic resistance and the inability to vaccinate infants less than one year old demands the development of new protective strategies. One strategy, 'maternal immunization', is to protect infants by passive immunity from an immunized mother, although its mechanism is still not fully understood. The current study aimed to acquire immunity against S. pneumoniae in infants by maternal immunization with pneumococcal common antigen, pneumococcal surface protein A (PspA). Four-week-old female mice were immunized with recombinant PspA intranasally twice a week for three weeks. Females were mated with age-matched males after immunization, and delivered offspring. The week-old offspring derived from and fostered by immunized mothers had more anti-PspA-specific antibody producing cells in the spleen than those derived from sham-immunized mothers. The offspring were raised up to four weeks old and were subcutaneously stimulated with recombinant PspA. The levels of anti-PspA IgG in sera after stimulation were significantly higher in the offspring derived from the immunized mothers and the induced specific antibody to PspA showed protective efficacy against systemic pneumococcal infection. Maternal immunization is suggested to be able to provide a sustained immune memory to offspring. The current study would be a milestone in the field of maternal immunization toward a universal pneumococcal vaccine.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011008 Pneumococcal Infections Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE. Streptococcus pneumoniae Infections,Infections, Pneumococcal,Infections, Streptococcus pneumoniae,Pneumococcal Diseases,Disease, Pneumococcal,Diseases, Pneumococcal,Infection, Pneumococcal,Infection, Streptococcus pneumoniae,Pneumococcal Disease,Pneumococcal Infection,Streptococcus pneumoniae Infection
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.
January 2011, PloS one,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).
December 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.
January 2011, Advances in oto-rhino-laryngology,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection.
January 2018, PloS one,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Immunization with Attenuated Pneumococcal Strains Provides Protection against Pneumococcal Colonization in Humans.
October 2023, American journal of respiratory and critical care medicine,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection.
January 2019, Vaccine,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae.
April 1997, Gene therapy,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Transcutaneous immunization with pneumococcal surface protein A in mice.
March 2018, The Laryngoscope,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.
November 2015, Clinical and vaccine immunology : CVI,
Masamitsu Kono, and Takuro Iyo, and Daichi Murakami, and Hideki Sakatani, and Denisa Nanushaj, and Muneki Hotomi
Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
July 1996, Microbial pathogenesis,
Copied contents to your clipboard!